Bruce Burlington, MD, is an infectious disease internist and currently serves as the industry representative on the FDA’s Drug Safety and Risk Management Advisory Committee. Dr. Burlington held senior management positions at the FDA and in the pharmaceutical industry. He now advises companies on drug development, risk management strategies, and preparation for key FDA meetings.